GSK gives up on rare diseases as gene therapy gets two customers
July 26, 2017 at 12:59 PM EDT
LONDON, July 26 (Reuters) - GlaxoSmithKline is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire see the field as a rich seam for profits.